SERPINA1 gene therapy(Tessera Therapeutics)

N/A

Report date: 2024/07/11 14:15:56

Base Information

Drug NameSERPINA1 gene therapy(Tessera Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAlpha-1-antiproteinase gene transference
TargetsAlpha-1-antiproteinase
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTessera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTessera Therapeutics Inc
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A